Related Experiment Video
Updated: Jan 21, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression
Georgia Tsaouli1, Elisabetta Ferretti2, Diana Bellavia1
1Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Roma, Italy.
Acute lymphoblastic leukemia (ALL) is a common childhood cancer. Understanding Notch and CXCR4 signaling pathways is crucial for developing new therapies to prevent relapse in ALL patients.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute lymphoblastic leukemia (ALL) is the most prevalent childhood cancer, with advancements in chemotherapy improving cure rates.
- Despite improved outcomes, a significant percentage of children and adults experience disease relapse, often in the central nervous system.
- Genetic alterations distinguish T-cell and B-cell lineages of ALL, influencing disease progression and relapse risk.
Purpose of the Study:
- To analyze the roles of deregulated Notch and CXCR4 signaling in the pathogenesis of T-cell and B-cell ALL.
- To identify molecular mechanisms modulating cancer cell invasion and disease relapse.
- To explore the implications of Notch-CXCR4 interactions in understanding ALL complexity and potential therapeutic targets.
Main Methods:
- Analysis of deregulated Notch (Notch1/Notch3) and CXCR4 receptor signaling in ALL.
- Investigation of molecular mechanisms in cancer cell invasion and pathogenesis.
- Examination of leukemia-stroma interactions within the tumor microenvironment.
Main Results:
- Deregulated Notch and CXCR4 signaling are implicated in ALL development and progression.
- The interplay between Notch and CXCR4 pathways influences critical cellular programs in lymphocyte transformation.
- Crosstalks in leukemia-stroma interactions may reveal novel targets for combating disease relapse.
Conclusions:
- Understanding the partnership between Notch and CXCR4 signaling is vital for comprehending T- and B-ALL complexity.
- Targeting these pathways and their interactions within the tumor microenvironment could lead to improved therapeutic strategies.
- Further research is needed to develop more selective and safer treatments for ALL progression and enhance overall hematological cancer therapy.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

